J9303 Panitumumab injection
Also known as: panitumumab, Vectibix
Injection of panitumumab, an epidermal growth factor receptor monoclonal antibody. Used for metastatic colorectal cancer.
In Plain Language
colon cancer injection; colorectal cancer treatment
Clinical Context
Used for metastatic colorectal cancer with KRAS wild-type status. Monotherapy or combination with chemotherapy and bevacizumab.
RVU Information
CPT J9303 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9303?
CPT J9303 (Panitumumab injection) is a J Codes (Drugs) code. Injection of panitumumab, an epidermal growth factor receptor monoclonal antibody. Used for metastatic colorectal cancer.
How is J9303 administered?
CPT J9303 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic colorectal cancer with KRAS wild-type status. Monotherapy or combination with chemotherapy and bevacizumab. It is used by Oncology, Gastroenterology, Surgery.
When is CPT J9303 used?
Used for metastatic colorectal cancer with KRAS wild-type status. Monotherapy or combination with chemotherapy and bevacizumab.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.